Polacrilin

Product Name

Polacrilin

Cat.No.

PE-0509

Particle Size

Inquiry

Price

Inquiry

Product Details

Category

Carrier Excipients

Grade

Pharmceutical Excipients

UNII

RCZ785HI7S

CAS Number

5060-22-16

Administration route

Oral, percutaneous

Dosage Form

Tablets, chrew, orally distegrating

Stability and Storage Conditions

Polaclin potassium and other Polaclin resins are stable to light, air and heat at their highest operating temperatures. Excessive heating causes thermal decomposition of the resin, producing one or more oxides of carbon, nitrogen, sulfur and/or amine. Polaclin resin should be sealed and stored in a cool and dry place.

Commonly used amount and the maximum amount

Maximum dosage of marketed tablets: 3.00mg; Maximum dose of transdermal administration: 1.10mg; Maximum dose of oral chewing: 8.1mg/g

Source and Preparation

Polaclin resin (Amberlite IRP-65) is a copolymerization of methacrylic acid and divinylbenzene (DVB).

Safety

Bolaclin potassium and other Bolaclin resins can be used in oral pharmaceutical preparations and are generally considered non-toxic and non-irritating. But excessive consumption of Polaclin can disrupt the body's electrolyte balance.

Incompatibilities

Incompatibility with strong oxidants, amines, especially tertiary amines, and certain substances that interact with Polaclin resins.

Online Inquiry

Please note: Our products and services are not intended to be used directly in diagnostic or therapeutic procedures.